NHPC share price jumps 2% as Q4 net profit rises 52% to Rs 920 crore
By Aman Shukla Published on May 21, 2025, 09:15 IST
Shares of NHPC Ltd rose over 2% in early trade following the announcement of its robust Q4 FY25 results. As of 9:15 AM, the shares were trading 2.52% higher at Rs 88.79.
The state-run hydropower company reported a 52% year-on-year (YoY) jump in consolidated net profit at ₹919.63 crore for the quarter ended March 2025, compared to ₹605 crore in the same period last year.
The sharp rise in profit was driven by higher total income, which increased to ₹2,672.11 crore in Q4 FY25 from ₹2,320.18 crore in Q4 FY24, as per the company's exchange filing. The positive earnings momentum has boosted investor sentiment, reflected in the upward movement of the stock.
In addition, NHPC's board of directors has recommended a final dividend of ₹0.51 per equity share (face value ₹10) for the financial year 2024-25. This dividend is subject to shareholder approval at the upcoming Annual General Meeting (AGM).
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
7 hours ago
- Business Upturn
NHPC declares COD for 3rd phase of Karnisar Solar Power Project in Bikaner
NHPC Limited has announced the commencement of commercial operations for the third phase of its 300 MW Karnisar Solar Power Project in Bikaner, Rajasthan. Following the successful completion of the trial run on June 5, 2025, the company declared the Commercial Operation Date (COD) for the third phase—adding 53.57 MW of capacity—effective June 7, 2025. With this milestone, the total commercially operational capacity of the Karnisar Solar Power Project now stands at 160.71 MW out of the planned 300 MW. This phased commissioning highlights NHPC's continued commitment to expanding its renewable energy portfolio and supporting India's clean energy transition. The project is a part of NHPC's broader strategy to diversify its energy mix beyond hydropower and contribute significantly to the nation's solar capacity. It aligns with India's ambitious renewable energy goals and showcases NHPC's growing presence in the solar sector. NHPC Q4 Results NHPC has reported a strong 52% year-on-year (YoY) jump in its consolidated net profit to ₹919.63 crore for the fourth quarter ended March 2025, compared to ₹605 crore in the same quarter last year. According to the company's regulatory filing, the impressive performance was primarily driven by a rise in total income, which grew to ₹2,672.11 crore in Q4 FY25 from ₹2,320.18 crore in Q4 FY24. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
a day ago
- Business Upturn
Lupin gets U.S. FDA tentative approval for Generic Oxcarbazepine ER Tablets
Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Oxcarbazepine Extended-Release (ER) Tablets in 150 mg, 300 mg, and 600 mg strengths. These tablets are the generic equivalent of Oxtellar XR® ER Tablets by Supernus Pharmaceuticals and are indicated for the treatment of partial-onset seizures in patients aged 6 years and above. Lupin's version of the drug will be manufactured at its Nagpur facility in India. According to IQVIA MAT April 2025 data, Oxcarbazepine ER Tablets (RLD Oxtellar XR®) recorded estimated annual sales of USD 206 million in the United States, underscoring the potential market opportunity for Lupin. Headquartered in Mumbai, Lupin is a leading global pharmaceutical company with a strong footprint in the U.S. and India. The company focuses on a broad range of therapy areas including central nervous system disorders, respiratory, cardiovascular, anti-infective, and women's health. It operates 15 manufacturing sites and 7 research centers globally, supported by over 23,000 employees. Lupin continues to expand its U.S. portfolio of complex generics and remains committed to delivering high-quality, affordable medicines that improve health outcomes for patients around the world. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
a day ago
- Business Upturn
Afcons Infrastructure secures Rs 700 crore Vinyl Project contract from Reliance Industries
Afcons Infrastructure Limited has recently informed exchanges that the company received a Letter of Award (LoA) from Reliance Industries Limited (RIL) for the execution of construction works related to its Vinyl Projects at Dahej, Gujarat. This major development reinforces Afcons' strong presence in the infrastructure and engineering sector. The estimated contract value is approximately ₹700 crore, excluding GST. This figure is indicative, with payments to be made based on the actual value of the work executed as per the terms of the contract. The project is expected to be completed by the end of June 2026. As per the scope of the LoA, Afcons Infrastructure will undertake civil, mechanical, and associated construction works. The responsibilities also include installation, testing, and commissioning services as part of the comprehensive project package. This contract win reflects Afcons Infrastructure's continued partnership with leading corporates like Reliance Industries, highlighting its execution capabilities in large-scale industrial and infrastructure projects. In the meantime, Afcons Infrastructure shares closed at ₹435.00 on Friday, gaining modestly after opening at ₹425.95. The stock hit an intraday high of ₹437.50 and a low of ₹425.90. Despite recent volatility, Afcons remains above its 52-week low of ₹398.00, though still trading well below its 52-week high of ₹570.00. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
